
Sign up to save your podcasts
Or


In this special bonus episode, hosts Terry Turner and Christian Simmons revisit the topic of GLP-1 drugs to dive into emerging health concerns for Saxenda and Victoza.
New research has uncovered a potential link between liraglutide, the active ingredient in those drugs, and permanent vision loss.
To better understand the impact of this issue, Terry and Christian once again speak with attorney Danielle Gold from Weitz & Luxenberg, who is working on vision loss cases involving GLP-1s.Learn more at Drugwatch.com.
By Drugwatch.com5
44 ratings
In this special bonus episode, hosts Terry Turner and Christian Simmons revisit the topic of GLP-1 drugs to dive into emerging health concerns for Saxenda and Victoza.
New research has uncovered a potential link between liraglutide, the active ingredient in those drugs, and permanent vision loss.
To better understand the impact of this issue, Terry and Christian once again speak with attorney Danielle Gold from Weitz & Luxenberg, who is working on vision loss cases involving GLP-1s.Learn more at Drugwatch.com.

14,966 Listeners

8,973 Listeners

3,504 Listeners

9,281 Listeners

9,170 Listeners

151 Listeners

49 Listeners

29,285 Listeners

1,665 Listeners

20,077 Listeners

201 Listeners

329 Listeners

1,595 Listeners